Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Rifampicin and Moxifloxacin for TBM
NCT01158755Phase 2Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rifampicin, moxifloxacin in tuberculous meningitis (TBM), sponsored by Universitas Padjadjaran. Started Oct 2010; status: completed.
02
Drugs
rifampicinmoxifloxacin
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT01158755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158755.